Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
March 26, 2021Open Access

Vaccine effectiveness of the first dose of ChAdOx1 nCoV-19 and BNT162b2 against SARS-CoV-2 infection in residents of Long-Term Care Facilities (VIVALDI study)

View Full Paper
Ask AI
Bookmark
Share

Authors

MSMadhumita ShrotriFarr InstituteMKMaria KrutikovUniversity College LondonTPTom PalmerUniversity College London

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Shrotri et al. (2021) studied this question.

synapsesocial.com/papers/6a7c180d0449e558d7c2cfb0https://doi.org/10.1101/2021.03.26.21254391
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Immunosenescence and Vaccination in Nursing Home Residents2009 · 110 citations
  2. 2Study Protocol: Understanding SARS-Cov-2 infection, immunity and its duration in care home residents and staff in England (VIVALDI)2020 · 35 citations
  3. 3Robust antibody responses in 70–80-year-olds 3 weeks after the first or second doses of Pfizer/BioNTech COVID-19 vaccine, United Kingdom, January to February 20212021 · 44 citations
  4. 4Duration of infectiousness and correlation with RT-PCR cycle threshold values in cases of COVID-19, England, January to May 20202020 · 991 citations
  5. 5Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine2020 · 15,770 citations